Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,361.1
-3.8 (-0.11%)

 

  • STI Straits Times Index
    3,361.1
    -3.8 (-0.11%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,648.9
    -8.6 (-0.52%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,461.7
    -131.5 (-0.46%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,901.2
    -30.5 (-1.04%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    21,046.2
    -422.9 (-1.97%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,403.3
    8.7 (0.14%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,066.6
    -6.4 (-0.31%)
    Index delayed 20 minutes
  • XAO XAO
    6,735.4
    -28.6 (-0.42%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 822.1M
  • Value: 1,036.3M
  • Rise: 148
  • Fall: 176
  • Unch: 513

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
TEE Intl0.101+0.001
LionGold0.001-
AEM1.100+0.060
YZJ Shipbldg SGD1.510+0.010
Koh Eco0.057+0.006
CapitaCom Trust2.150-0.020
SunMoonFood^0.058-0.001
SingTel3.520-0.020
ISR Capital^0.003-
Alliance Mineral0.128+0.011

World Indices

World Indices
Name Last Change
Nasdaq 8,185.2 -37.6
HSI 28,461.7 -131.5
HSCEI 10,784.5 -63.4
Jakarta 6,403.3 +8.7
Nikkei 225 21,046.2 -422.9
SSE Comp 2,901.2 -30.5
Shanghai A 3,038.6 -32.0
Shanghai B 288.7 -1.8
ShenZhen A 1,619.5 -26.9
ShenZhen B 968.7 -6.6
Taiwan W 10,799.3 -29.2
PSE Comp 0.0
KOSPI 2,066.6 -6.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Annica ANNICA HOLDINGS LIMITED
Quotes 10 Minutes Delayed. Updated at 18 Jul 2019 09:57
Last (SGD): 0.001 Change: - High: 0.001 Remarks: -
Change (%): - Low: 0.001
Open 0.001 Yesterday's Close 0.001
Buy Price - Sell Price 0.001
Buy Volume ('000) - Sell Volume ('000) 480,274.2
Cumulative Volume ('000) 0.1 Cumulative Value -
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a -0.00024 Trailing EPS (SGD) e -0.00024 NAV (SGD) b 0.0003
PE a - Trailing PE f - Price / NAV b 3.3333
Dividend (SGD) d - Cash In Hand (SGD) g 0.0001 Issued & Paid-up Shares c 16,674,767,000
Dividend Yield (%) d - Price / Cash In Hand g 10.000 Treasury Shares h -
Beta - 75 Daysi - R-Squared - 75 Days(%)i - Market Cap (M) 16.675
Beta - 500 Daysi - R-Squared - 500 Days (%)i - Enterprise Value (M) 15.890
Piotroski F Score 2 Exchange Code 5AL Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 0.0 6-Month VWAP 0.001 Free Float (%) -
Under CPF Investment Scheme (CPFIS) Yes
Sector & Industry Financial and Insurance Activities - Medical Specialties
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 12 Jul 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Annica SGX 16.675 - - 3.3333 -
Industry Medical Specialties SGX 692.571 32.733 33.140 4.0618 1.760
Index FTSE ST Catalist Index SGX 79.462 117.554 - 0.9077 2.247
Local Peer Top Glove SGX 3,994.519 27.664 27.764 4.8372 1.819
Local Peer Biolidics SGX 67.900 - - 5.4054 -
Local Peer UG Healthcare SGX 32.861 7.579 9.973 0.7623 1.369
Local Peer Yunnan Energy SGX 26.442 - - 0.5069 -
Local Peer Medtecs Intl SGX 17.032 13.656 13.658 0.2003 -
Global Peer ABBOTT LABORATORIES NYSE 151,296.077 64.299 58.079 - 1.346
Global Peer MEDTRONIC PLC NYSE 135,349.867 29.227 29.227 2.7021 1.981
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 114,794.547 39.072 36.167 4.1453 0.256
Global Peer DANAHER CORP NYSE 99,980.183 37.716 41.458 3.3375 0.449
Global Peer STRYKER CORP NYSE 77,587.185 21.837 22.029 6.6354 0.931
Global Peer BECTON DICKINSON & CO NYSE 67,932.004 427.248 73.282 3.1882 1.192
Global Peer INTUITIVE SURGICAL INC NASDAQ 60,437.552 53.584 52.701 8.6042 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 58,741.056 35.153 32.688 6.3621 -
Global Peer BAXTER INTERNATIONAL INC NYSE 42,165.385 25.964 26.653 5.5147 0.888
Global Peer EDWARDS LIFESCIENCES CORP NYSE 39,565.340 54.784 51.699 11.4765 -
Other Global Peers ZIMMER BIOMET HOLDINGS INC (NYSE), IDEXX LABORATORIES INC (NASDAQ), ALIGN TECHNOLOGY INC (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), RESMED INC (NYSE), COOPER COS INC (NYSE), TELEFLEX INC (NYSE), WATERS CORP (NYSE), DEXCOM INC (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), HOLOGIC INC (NASDAQ), STERIS PLC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), ABIOMED INC (NASDAQ), PERKINELMER INC (NYSE), BIO RAD LABORATORIES INC (NYSE), QIAGEN NV (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), COCHLEAR LTD (ASX), MASIMO CORPORATION (NASDAQ), BRUKER CORPORATION (NASDAQ), INSULET CORPORATION (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), NOVOCURE LTD (NASDAQ), HAEMONETICS CORP (NYSE), PENUMBRA INC (NYSE), FISHER & PAYKEL HEALTHCARE CORP (ASX), ICU MEDICAL INC (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), WEIGAO GROUP (HKEx), GLOBUS MED INC (NYSE), HARTA (Bursa), TANDEM DIABETES CARE INC (NASDAQ), LIVANOVA PLC (NASDAQ), NEOGEN CORP (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), CANTEL MEDICAL CORP (NYSE), MERIT MEDICAL SYSTEMS (NASDAQ), NUVASIVE INC (NASDAQ), TOPGLOV (Bursa), GLAUKOS CORPORATION (NYSE), EBOS GROUP (ASX), CONMED CORP (NASDAQ), QUIDEL CORP (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), AVANOS MEDICAL INC (NYSE), NEVRO CORP (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), BIOTELEMETRY INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), ATRION CORP (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), INOGEN INC (NASDAQ), CAREDX INC (NASDAQ), MICROPORT (HKEx), SILK ROAD MEDICAL INC (NASDAQ), ATRICURE INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), CRYOLIFE INC (NYSE), AXONICS MODULATION TECHNLOGS INC (NASDAQ), NANOSONICS LIMITED (ASX), LANTHEUS HOLDINGS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), VIEWRAY INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), ANGIODYNAMICS INC (NASDAQ), AXOGEN INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), CERUS CORP (NASDAQ), LIFETECH SCI (HKEx), CIRC (HKEx), QUOTIENT LTD (NASDAQ), HESKA CORP (NASDAQ), AK MEDICAL (HKEx), ORTHOPEDIATRICS CORP (NASDAQ), CORMEDIX INC (NYSE American), SURMODICS INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), SUPERMX (Bursa), SI BONE INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), CORINDUS VASCULAR ROBOTICS INC (NYSE American), TRANSMEDICS GROUP INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), GENMARK DIAGNOSTICS INC (NASDAQ), CUTERA INC (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), YESTAR HEALTH (HKEx), GOLDEN MEDITECH (HKEx), VAPOTHERM INC (NYSE), UTAH MEDICAL PRODUCTS (NASDAQ), AVEDRO INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), SIENTRA INC (NASDAQ), RTI SURGICAL HOLDINGS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), INOVIO PHARMACEUTICALS INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), ZYNEX INC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), NEURONETICS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), SOLITON INC (NASDAQ), MISONIX INC (NASDAQ), CONFORMIS INC (NASDAQ), IRADIMED CORP (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), CRH MEDICAL CORP (NYSE American), PW MEDTECH (HKEx), ROCKWELL MEDICAL INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), INTRICOM CORP (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), MODERN DENTAL (HKEx), INVACARE CORP (NYSE), FONAR CORP (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), ENDOLOGIX INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), YUNNAN ENERGY (HKEx), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), NEUROTROPE INC (NASDAQ), COMPUMEDICS (ASX), SDI LTD (ASX), CYCLOPHARM LIMITED (ASX), SOMNOMED LIMITED (ASX), ONCOCYTE CORP (NYSE American), APOLLO ENDOSURGERY INC (NASDAQ), KELFRED (HKEx), ELLEX MEDICAL LASERS LTD (ASX), ZOSANO PHARMA CORP (NASDAQ), ALPHA PRO TECH (NYSE American), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), VINCENT MED (HKEx), IRIDEX CORP (NASDAQ), MRI INTERVENTIONS INC (NYSE American), NUVECTRA CORPORATION (NASDAQ), IMMUCELL CORP (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), ELECTROMED INC (NYSE American), ELECTROCORE INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), RESONANCE HEALTH LTD (ASX), RESPIRI LTD (ASX), CELSION CORPORATION (NASDAQ), MICRO-X LTD (ASX), OVENTUS MEDICAL LTD (ASX), PAVMED INC (NASDAQ), IMPEDIMED LIMITED (ASX), DAXOR CORP (NYSE American), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), BIOLASE INC (NASDAQ), RESTORATION ROBOTICS INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), TITAN MEDICAL INC (NASDAQ), NEOVASC INC (NASDAQ), BIOMERICA INC (NASDAQ), IMPRESSION HEALTHCARE LIMITED (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), INSPIREMD INC (NYSE American), PREDICTIVE ONCOLOGY INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), OBALON THERAPEUTICS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), LIFE HEALTHCARE (HKEx), OBJ LIMITED (ASX), VIVEVE MEDICAL INC (NASDAQ), ATOSSA GENETICS INC (NASDAQ), LBT INNOVATIONS LTD (ASX), CHECK-CAP LTD (NASDAQ), OPTISCAN IMAGING (ASX), AVINGER INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), ADVENTA (Bursa), EMVISION MEDICAL DEVICES LTD (ASX), DARIOHEALTH CORP (NASDAQ), VALERITAS HOLDINGS INC (NASDAQ), CYANOTECH CORP (NASDAQ), DYNATRONICS CORP (NASDAQ), CARDIEX LTD (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), USCOM LTD (ASX), ANALYTICA (ASX), REALM THERAPEUTICS PLC SPONSORED ADS (NASDAQ), COMBEST HOLD (HKEx), DIMERIX LTD (ASX), DIGIRAD CORP (NASDAQ), LKL (Bursa), ALLEGRA ORTHOPAEDICS LIMITED (ASX), HUAKANG BIOMED (HKEx), TENAX THERAPEUTICS INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), CESCA THERAPEUTICS INC (NASDAQ), MICRON SOLUTIONS INC (NYSE American), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), AETHLON MEDICAL (NASDAQ), CHF SOLUTIONS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), STHAI (SET), CH DEMETER FIN (HKEx), IMAGION BIOSYSTEMS LIMITED (ASX), NEUROMETRIX INC (NASDAQ), METALICITY LIMITED (ASX), ADHERIUM LIMITED (ASX), SINTX TECHNOLOGIES INC (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), MY MEDICARE (HKEx), ADMEDUS LTD (ASX), MEDIGARD LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days ---
10 Days ---
20 Days ---
Medium Term Return 3 Months ---
6 Months ---
1 Year ---
Long Term Return 2 Years ---
3 Years ---
5 Years --0.013
-92.86 %
Annualised Return Annualised --
-41.01 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.001 - 0.001 Change From 1 Year Low - % Change From 1 Year Low (%) -
Change From 1 Year High - % Change From 1 Year High (%) -
2 Years Range 0.001 - 0.001 Change From 2 Years Low - % Change From 2 Years Low (%) -
Change From 2 Years High - % Change From 2 Years High (%) -
5 Years Range 0.001 - 0.015 Change From 5 Years Low - % Change From 5 Years Low (%) -
Change From 5 Years High -0.014 % Change From 5 Years High (%) -93.33
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Company was incorporated in Singapore on 20 August 1983. On 20 March 2001, it was converted into a public limited company at which time it changed its name to Oculus Limited. It is focused on the innovation, manufacturing and marketing of colour lenses. Its colour lenses are principally marketed under the FreshKon® and Unicon™ brand names globally. Aside from colour lenses, Oculus also offers disposable daily clear lenses, disposable bi-weekly and monthly clear lenses under FreshKon® brand, and gas permeable lenses and solution under the Boston® brand to its broad customer base.With direct presence in Singapore, China, Taiwan, Hong Kong and Malaysia, its products are sold in over 50 countries globally.

IPO Performance

Listing Date 11 Apr 2001 Full Subscription Rate (x) 1.03
No of Placement Shares (M) 19.76 No of Public Offer Shares (M) 2.20 Public Offer Subscription Rate (x) 1.29
IPO Price (SGD) a 0.193 First Day Close (SGD) a 0.160 First Week Close (SGD) a 0.168
Current vs IPO Price (%) -99.48 First Day Gain (%) -17.10 First Week Gain (%) -12.95
Notes:
  1. Adjusted for the following: Rights Issue 1 for 1 @ $0.015 on 14/12/2012

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2018 Dec 2018 Part 1(0.34 MB)
Part 2(4.40 MB)
Annual Report 2017 Dec 2017 Part 1(0.03 MB)
Part 2(0.31 MB)
Part 3(0.45 MB)
Annual Report 2016 Dec 2016 Part 1(0.53 MB)
Annual Report 2015 Dec 2015 Part 1(1.96 MB)
Annual Report 2014 Dec 2014 Part 1(0.78 MB)
Annual Report 2013 Dec 2013 Part 1(0.61 MB)
Annual Report 2012 Dec 2012 Part 1(0.33 MB)
Annual Report 2011 Dec 2011 Part 1(0.28 MB)
Annual Report 2010 Dec 2010 Part 1(1.97 MB)
Annual Report 2009 Dec 2009 Part 1(0.02 MB)
Part 2(0.37 MB)
Annual Report 2008 Dec 2008 Part 1(0.45 MB)
Annual Report 2007 Dec 2007 Part 1(0.70 MB)
Annual Report 2006 Dec 2006 Part 1(1.12 MB)
Annual Report 2005 Dec 2005 Part 1(6.97 MB)
IPO Prospectus
IPO Prospectus 2001 Mar 2001 Part 1(2.58 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
18 Jul 2019 0.001 0.001 0.001 0.001 100 0.0010
17 Jul 2019 0.001 0.001 0.001 0.001 100 0.0010
16 Jul 2019 0.001 0.001 0.001 0.001 100 0.0010
15 Jul 2019 0.001 0.001 0.001 0.001 - -
12 Jul 2019 0.001 0.001 0.001 0.001 100 0.0010
11 Jul 2019 0.001 0.001 0.001 0.001 100 0.0010
10 Jul 2019 0.001 0.001 0.001 0.001 100 0.0010
09 Jul 2019 0.001 0.001 0.001 0.001 100 0.0010
08 Jul 2019 0.001 0.001 0.001 0.001 - -
05 Jul 2019 0.001 0.001 0.001 0.001 100 0.0010
04 Jul 2019 0.001 0.001 0.001 0.001 100 0.0010
03 Jul 2019 0.001 0.001 0.001 0.001 100 0.0010
02 Jul 2019 0.001 0.001 0.001 0.001 100 0.0010
01 Jul 2019 0.001 0.001 0.001 0.001 - -
28 Jun 2019 0.001 0.001 0.001 0.001 - -
27 Jun 2019 0.001 0.001 0.001 0.001 - -
26 Jun 2019 0.001 0.001 0.001 0.001 100 0.0010
25 Jun 2019 0.001 0.001 0.001 0.001 100 0.0010
24 Jun 2019 0.001 0.001 0.001 0.001 100 0.0010
21 Jun 2019 0.001 0.001 0.001 0.001 100 0.0010
20 Jun 2019 0.001 0.001 0.001 0.001 100 0.0010
19 Jun 2019 0.001 0.001 0.001 0.001 100 0.0010
Summary
Current 2 Weeks
(05 Jul 2019 to 18 Jul 2019)
0.001 0.001 0.001 0.001 800 -
Previous 2 Weeks
(21 Jun 2019 to 04 Jul 2019)
0.001 0.001 0.001 0.001 700 -
4 Weeks from
(23 May 2019 to 20 Jun 2019)
0.001 0.001 0.001 0.001 1,800 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.